Organon is paying $175 million upfront to buy ... while in August it expanded an agreement with Eli Lilly to distribute migraine therapy Emgality (galcanezumab) in Europe and other ex-US markets.

(1) Emgality is a trademark registered in the United States in the name of Eli Lilly and Company (used under license). Organon acquired certain European licensing and distribution rights to ...

Organon & Co. (OGN) Q2 2024 Earnings Call Transcript Eli Lilly, Organon expand distribution deal for migraine drug Roth MKM says Small-Cap Value reaches key technical support, lists 14 "bullish ...

Furthermore, Organon focuses on carrying out company growth ... such as the one for migraine medications with Eli Lilly (NYSE:LLY), demonstrate its emphasis on utilizing its commercial ...

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health ...